http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112137998-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b69c334ee6a78456946a479cab5bdb2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd4bdb71dd03dcdbec9fda2d3ae1dbb5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K67-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 2020-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0e3baa52c8f9e9b4b25d0467f0f4f5d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7c50ea1b66b23aa1542ab27c2ecf710 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c105ae0a3c9fa72507fa608ce5314704 |
| publicationDate | 2020-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112137998-A |
| titleOfInvention | Application of an active ingredient in the preparation of a medicine for preventing and treating necrotizing enterocolitis |
| abstract | The present invention provides the use of an active ingredient, which is characterized in that it is a compound represented by the following structural formula or its stereoisomer, geometric isomer, tautomer, racemate, hydrate, and solvate , metabolites, and pharmaceutically acceptable salts or prodrugs: Wherein: R 1 , R 2 , R 3 , R 4 are hydrogen, alkyl, alkoxy, aryl, heteroaryl, halogen substituted in any or any number of rings on the ring; the purpose is for the preparation of the prevention and treatment of necrosis Medications for enterocolitis (NEC). Studies have shown that the active ingredient can be used to prevent and treat NEC, improve intestinal pathological damage caused by necrotizing enterocolitis, reduce mortality, and reduce the decline of cognitive function, learning and memory caused by the disease and other sequelae. It has great promotion value to reduce the burden of NEC neurodevelopmental sequelae on families and society. |
| priorityDate | 2020-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.